Prevest Denpro's Q2 2024-25 Financial Results Show Mixed Performance, Highest Sales and PAT in 5 Quarters.

Operating Profit Margin (OPM) - Quarterly: Lowest at 29.6% in the last five quarters.Decrease in operating profit margin may indicate higher expenses or lower sales.
Debt to Equity Ratio - Quarterly: Highest at 0.01 in the last five quarters.Low debt to equity ratio indicates low financial risk for the company.

Prevest Denpro, a microcap company in the medical equipment/supplies/accessories industry, has recently declared its financial results for the quarter ending September 2024. The stock call for the company by MarketsMOJO is 'Hold'.

According to the financials, Prevest Denpro has shown a flat performance in the second quarter of the fiscal year 2024-25. However, there has been an improvement in the company's score from -3 to 2 in the last three months.

The company's net sales for the quarter were the highest in the last five quarters at Rs 16.27 crore, indicating a positive trend in near-term sales. The profit after tax (PAT) for the quarter was also the highest in the last five quarters at Rs 4.82 crore, showing a positive trend in near-term profitability. The PAT has also grown at 22.6% over the average of the previous four quarters, which is a positive sign for the company's financial health. The earnings per share (EPS) for the quarter were also the highest in the last five quarters at Rs 40.17, indicating an increase in profitability and higher earnings for shareholders.

However, there are some areas that need improvement for Prevest Denpro. The non-operating income for the quarter was the highest in the last five quarters at Rs 1.04 crore, but this may not be sustainable as it comes from non-business activities. The operating profit margin (OPM) for the quarter was the lowest in the last five quarters at 29.6%, which could be a result of higher expenses or lower sales. The debt to equity ratio for the quarter was also the highest in the last five quarters at 0.01, indicating low financial risk for the company.

Overall, Prevest Denpro has shown a mixed performance in the second quarter of the fiscal year 2024-25. While there are some positive trends in terms of sales and profitability, there are also areas that need improvement. Investors are advised to hold their stock in the company for now, as recommended by MarketsMOJO.